Fundraising Fox

Martin Birk

CFO at Resistell

Zürich Metropolitan Area

Find your path to Martin

648 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.

Hannes Voucko-GlocknerunlockedMartin: together at Massachusetts Institute of Technology (2024–2025)
×3Martin: together at Massachusetts Institute of Technology
×2Martin: together at Boardy
Martin: together at ESCP

About

Martin Birk is a fractional CFO/COO with over 16 years of experience in life sciences, medtech, and regulated startups, currently serving as CFO at SpiroChem. His work covers strategic finance and cash planning, fundraising and investor reporting, public grants including Innosuisse, SNF, and EU programs, and the application of generative AI to finance and operational workflows. He is co-founder, CEO, and board member of TransHeps AG, which focuses on DILI diagnostics and liver cell models, and a founding member of the Boardy Pro Advisory Board.

CFO at Resistell

Intro paths

In turn, Martin can intro founders to Resistell's investors below.

Co-founders at Resistell

DDDr. Danuta Cichocka
Dr. Danuta CichockaCEO, Co-Founder, Board Member

Experience

  1. SpiroChemCFOcurrent2025 — presentBasel, Switzerland
  2. ResistellFractional CFOcurrent2023 — presentMuttenz, Basel-Country, Switzerland
  3. TransHepsCo-Founder, CEO & Board Membercurrent2024 — presentZurich, Switzerland
  4. TransHepsCFO/COO2024Zurich, Switzerland
  5. BoardyFounding Member, Boardy Pro Advisory Boardcurrent2026 — present
  6. BoardyDeal Partnercurrent2026 — presentZurich, Switzerland
  7. InSpheroInterim CFO2022 — 2023Schlieren, Zurich, Switzerland
  8. InSpheroHead of Finance & Controlling (IT, Legal)2018 — 2022Schlieren, Kanton Zürich, Schweiz
  9. Manor AGHead of Management Reporting2017 — 2018Basel, Basel, Switzerland
  10. LonzaManager - Corporate Controlling2014 — 2016Basel, Basel, Switzerland
  11. CoopInternal Audit Manager2013 — 2014Basel
  12. LonzaSenior Auditor2011 — 2013Basel
  13. BayerBusiness Auditor2008 — 2011Leverkusen

Skills & more

Analysis1ManagementDecision-MakingInvestorbeziehungenGenerative AI / LLMs for FinanceTurnaround-ManagementBoard GovernanceFundraisingDigital Transformation2Board Governance1C-Level LeadershipGrowth Strategy
+12 moreDigital TransformationLifesciencesFinanceBusiness StrategyAuditingInternal AuditInternal ControlsFinancial AnalysisProject ManagementDue DiligenceFinancial ReportingFinancial Audits

Languages English · French · German · Spanish

  • Chief Operating Officer (COO) ProgramEmeritus
  • Supply Chain Management: Leading with AI and Digital TransformationEmeritus
  • Designing and Building AI Products and ServicesEmeritus
  • Psychologie des Verhandelns und des ÜberzeugensLinkedIn
  • Balanced Scorecard and Key Performance IndicatorsLinkedIn
  • Running a Profitable Business: Understanding Financial RatiosLinkedIn

From Martin's professional profile.

Frequently asked questions

Who is Martin Birk?
Martin Birk is a fractional CFO/COO with over 16 years of experience in life sciences, medtech, and regulated startups, currently serving as CFO at SpiroChem. His work covers strategic finance and cash planning, fundraising and investor reporting, public grants including Innosuisse, SNF, and EU programs, and the application of generative AI to finance and operational workflows. He is co-founder, CEO, and board member of TransHeps AG, which focuses on DILI diagnostics and liver cell models, and a founding member of the Boardy Pro Advisory Board.
Where does Martin Birk work?
Martin Birk is CFO at Resistell.
Where did Martin Birk go to school?
Martin Birk studied at Massachusetts Institute of Technology (Chief Operating Officer Program, Strategy); University of Louisville (Master's degree, Industrial Engineering); Justus Liebig University Giessen (MSc, Biochemistry).

Same school

Shared employers